Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001477932-17-001448
Filing Date
2017-03-31
Accepted
2017-03-31 11:31:33
Documents
1
Period of Report
2016-12-31
Effectiveness Date
2017-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K curr_nt10k.htm NT 10-K 14683
  Complete submission text file 0001477932-17-001448.txt   15769
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 333-204857 | Film No.: 17728795
SIC: 2673 Plastics, Foil & Coated Paper Bags